Dr. Dalia Dawoud is a lecturer at the Clinical and Pharmaceutical Sciences Department, University of Hertfordshire, UK. She is an expert in Pharmacoeconomics and health technology assessment (HTA), with a special focus on the pharmacoeconomic aspects of diabetes management in general and long-acting insulin therapy in particular. Dr. Dawoud has published a number of articles from her work on the NICE guideline for the diagnosis and management of Type 1 diabetes in adults (NG89). She is Associate Editor for Pharmacoeconomics and Outcomes Research for the journal Research in Social and Administrative Pharmacy.
Diabetes, Pharmacology, Diabetes Management, Insulin Therapy
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
